These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11122806)

  • 1. Concurrent chemoradiotherapy in head and neck cancer.
    Urba SG
    Curr Oncol Rep; 1999; 1(2):105-9. PubMed ID: 11122806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer.
    Adelstein DJ
    Curr Opin Oncol; 1998 May; 10(3):213-8. PubMed ID: 9619357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant chemotherapy (nedaplatin/UFT) after concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma].
    Kubota A; Furukawa M; Komatsu M; Hanamura H; Sugiyama M
    Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):149-56. PubMed ID: 16615429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent chemoradiation in the treatment of head and neck cancer.
    Haffty BG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):719-42, vi-vii. PubMed ID: 10494509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
    Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM
    Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
    Kies MS; Haraf DJ; Athanasiadis I; Kozloff M; Mittal B; Pelzer H; Rademaker AW; Wenig B; Weichselbaum RR; Vokes EE
    J Clin Oncol; 1998 Aug; 16(8):2715-21. PubMed ID: 9704722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer.
    Melotek JM; Cooper BT; Koshy M; Silverman JS; Spiotto MT
    J Otolaryngol Head Neck Surg; 2016 Nov; 45(1):62. PubMed ID: 27881143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemoradiation paradigm in head and neck cancer.
    Seiwert TY; Salama JK; Vokes EE
    Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer.
    Tang C; Chan C; Jiang W; Murphy JD; von Eyben R; Colevas AD; Pinto H; Lee-Enriquez N; Kong C; Le QT
    Head Neck; 2015 Mar; 37(3):386-92. PubMed ID: 24431011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Gyawali B; Shimokata T; Honda K; Ando Y
    Cancer Treat Rev; 2016 Mar; 44():10-6. PubMed ID: 26924194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegulated liposomal doxorubicin and cisplatin given concurrently with conventional radiotherapy: a phase I dose-escalation trial for patients with squamous cell carcinoma of head and neck and lung.
    Varveris H; Kachris S; Mazonakis M; Lyraraki E; Markouizou A; Karabekios S; Tzedakis A; Perisinakis K; Damilakis J; Vlachaki M
    Oncol Rep; 2004 Aug; 12(2):473-81. PubMed ID: 15254718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancer.
    Yoo DS; Kirkpatrick JP; Craciunescu O; Broadwater G; Peterson BL; Carroll MD; Clough R; MacFall JR; Hoang J; Scher RL; Esclamado RM; Dunphy FR; Ready NE; Brizel DM
    Clin Cancer Res; 2012 Mar; 18(5):1404-14. PubMed ID: 22253412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
    Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G
    Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.